Description
Tesamorelin Refill 10mg is the Core Research listing for 10mg nominal in the separately listed refill-cartridge presentation. Tesamorelin (TH9507-type GHRH analogue). It is supplied for in-vitro laboratory research only, not for human or veterinary use. The exact supplied chemical form, current batch results and any finished-format specifications must be checked against the documentation applicable to this item.
What you receive and what the label means
The current catalogue identifies this product as Tesamorelin Refill 10mg. This page distinguishes the material name and labelled quantity from independently measured content. Stock and current price are supplied by the live WooCommerce purchase panel rather than duplicated as static claims in the description.
The stated nominal amount is not a prepared solution concentration, analytical purity percentage or guarantee of the number of experiments possible. Those further properties depend on the exact material form, documentation and laboratory method.
| Item | Detail |
|---|---|
| Catalogue product | Tesamorelin Refill 10mg |
| Labelled amount | 10mg nominal |
| Named material / declared composition | Tesamorelin (TH9507-type GHRH analogue) |
| Physical presentation | the separately listed refill-cartridge presentation |
| Supply boundary | Laboratory research only; no human or veterinary use |
Which product format is the right catalogue item?
The related listings below differ in presentation and, where stated, composition. Do not assume their packages, compatible hardware, storage conditions or analysed content are identical merely because the molecular name overlaps. vial and pen-format comparison.
| Product | Declared format / relevant distinction |
|---|---|
| Tesamorelin 10mg | Standalone lyophilised vial |
| Tesamorelin Refill 10mg (this item) | Refill-cartridge item |
Research mechanisms and what studies actually found
The following sections distinguish the molecular identity, measured experimental endpoint and limitations of published work. Literature on a pure molecule, animal model or clinical formulation is not analytical evidence for this particular Core Research supply. The cited sources support the described scientific context, not a product-specific efficacy or batch claim.
A chemically modified GHRH analogue
Tesamorelin is referred to as TH9507 in development literature. It is related to human GHRH(1–44), with an N-terminal trans-3-hexenoyl modification reported in the studied molecule. That specific modification is relevant to proteolytic susceptibility and pharmacology; a generic “GHRH peptide” designation would miss the molecular distinction. The supplied salt or counter-ion and measured mass still require evidence for this refill. 1
GHRH-receptor biology and experimental endpoints
The GHRH receptor is a G-protein-coupled receptor studied in anterior pituitary cells. Experimental activation is associated with cAMP signalling and growth-hormone secretion. A higher hormone measurement in a study is a different endpoint from a demonstrated clinical outcome or an analytical identity test. A result for the active substance cannot certify a separate commercial cartridge. 1,2
What controlled human programmes measured
Falutz and colleagues studied tesamorelin/TH9507-containing clinical preparations in controlled human investigations, including body-composition endpoints in HIV-associated lipodystrophy research. Study populations, comparators, formulations and follow-up matter. These outcomes neither test the Core Research refill nor establish a human-use protocol or medical suitability for it. 2,3
Distinguishing tesamorelin from other growth-signalling materials
Tesamorelin is a GHRH-related analogue, whereas ipamorelin is a ghrelin-receptor-class secretagogue. CJC-1295 No DAC is another GHRH-analogue catalogue label but does not share all structural features or evidence of TH9507. Research results should be transferred across these names only when exact compound identity, assay and conditions justify the comparison.
Finished-format checks specific to this item
Cartridge format: The refill item is listed as a separate cartridge rather than the complete pen. Ask which housing or device it is compatible with; the product name alone is not a compatibility test.
For evaluation of this finished item, identify its container, chemical species and nominal amount; confirm any prepared-solution or reconstitution state. Check pen-format verification and cartridge capacity and dispensing verification when mechanical performance matters.
Batch documentation and evidence before purchase
For a pre-purchase question, use Request batch documentation or email info@core-research.net, naming Tesamorelin Refill 10mg and its refill format. You do not need a previous container lot number to enquire. Ask which dispatch lot and exact presentation any proposed report covers.
Read the certificate for sample identification, test method, analyte(s), units, measured content, chromatographic results and issuer. Identity, chromatographic purity and quantitative content answer different questions; one HPLC peak-area value alone does not prove the labelled mass. Laboratory handling and evidence requirements depend on the actual chemical form.
For context see how to read a peptide CoA, HPLC and purity testing and mass-spectrometry identity testing. These guides explain how documents are read; they do not assert that a current lot passed any unobserved test.
Additional documentation for the finished format
For this presentation, check the container and product specification in addition to material identity: fill volume or dry-fill basis, declared constituents, formulation vehicle where applicable, lot traceability, container integrity and any validated compatibility or dispensing property your method requires.
Do not automatically transfer an HPLC result, solvent condition or expiry statement from a different vial, refill, pen or manufacturing lot. Where a material attribute is essential to procurement, request it before ordering rather than assuming it from related items.
Storage, receipt and handling
Follow the storage instructions supplied for this particular product and lot. A fixed dry-material temperature or shelf life is not stated here without authenticated product-specific evidence. Solution stability, if applicable, is a separate question that can depend on solvent, pH, concentration, container and exposure history.
At receipt, inspect the material label, lot and quantity, packaging and closure against the order; record discrepancies before laboratory use. See the research-product receiving checklist and laboratory storage guidance. For late or unexpectedly warm delivery, consult warm or delayed research shipments.
Ordering and laboratory procurement questions
Can I ask for the lot documentation before ordering?
Yes. The Request batch documentation route accepts product/presentation enquiries before an order. Ask whether the available report covers the lot expected to be supplied; availability and analytical scope must not be assumed.
Does this refill include a complete pen?
No complete pen is established by the refill-only listing. It is a separately purchasable cartridge-format item. Confirm compatible hardware and any accessories with Core Research before placing an order.
Where do orders ship from?
Core Research’s published shipping policy describes dispatch from Birmingham, UK, in plain outer packaging. Available carrier options, shipping charges and tracking depend on the actual order and service. The checkout and shipping policy provide the applicable current information.
Does the labelled amount determine experimental concentration?
No. The labelled mass alone does not determine a prepared concentration, method, recovery, sample number or material content verified by assay. Those require defined volume and material-specific laboratory controls; the page provides no personal-use or administration directions.
Can an institution ask for a quotation?
Yes. The Institutional Procurement page provides a quotation and purchase-order-reference enquiry pathway. State the requested item, quantity, delivery details and any need for a particular lot or document before ordering.
What if the item arrives damaged or differs from the order?
Contact info@core-research.net with the order number, labelled product/lot identifiers and photographs. Keep the packaging and segregate the item from laboratory use until the discrepancy is addressed.
Order or enquire about Tesamorelin Refill 10mg
Use the native purchase panel for current pricing, stock and quantity selection. For an analytical or format question, contact Core Research before purchase; for shipping information see Shipping & Delivery.
The research discussed above is not a human-use instruction or a claim about medical effects of the supplied item. Read the Research Use Only policy and testing and quality methodology for the published supply and quality framework.
Selected research and identity references
[1] Ferdinandi ES et al. (2007), TH9507 preclinical GHRH analogue pharmacology. Source.
[2] Falutz J et al. (2005), Randomised tesamorelin/TH9507 dose-ranging trial. Source.
[3] Falutz J et al. (2010), Pooled controlled trial analysis of tesamorelin in HIV-associated abdominal-fat research. Source.




